Academic Venture Exchange connects high impact entrepreneurs to early stage ventures spinning out of 40 research universities.
Startups profiled on the AVX platform have raised $152m in follow-on investment between October 2021 and March 2023.
In Q1 2023, our team facilitated the introduction of 30 C-suite entrepreneurs to Principal Investigators. Diligence has begun on seven new CEO candidates.
170 IP-based ventures are presented on the AVX platform. Recently 28 new startups were added and we have offered a sample below. Sign In on the platform to view their complete profiles.
Brown University
Carnegie Mellon University
Columbia University
George Washington University
University of California, Los Angeles
University of Pennsylvania
Washington University in St. Louis
Venture Spotlight
Nanopath (Dartmouth College) closed a $10m Series A funding round led by Norwest Venture Partners and MedTech Convergence Fund. The investment will support development and commercialization of Nanopath's biosensing platform that aims to transform how women's pelvic and gynecologic infections are diagnosed. Alison Burklund, cofounder and CTO, was featured on the Healthcare 2023 Forbes 30 under 30.
ClostraBio (The University of Chicago) announced their $4m Series A financing led by Portal Innovations. The company aims to use the funding to complete remaining preclinical studies to advance CLB-004 towards first-in-human clinical studies treating mild-to-moderate ulcerative colitis. Their momentum continued with the appointment of Ritu Shah as CEO.
In January 2023, ClostraBio had a major breakthrough in targeted metabolite delivery to transform intestinal health using oral nanoparticles in Phase 1.